Drew Moghanaki: Dr. Wen-Zhao Zhong reminding us of the fanfare around drugs and surgery for NSCLC

“Dr. Wen-Zhao Zhong presents a slide at ELIXR24 reminding us of the fanfare around drugs and surgery for NSCLC (non-small cell lung cancer ). It’s intriguing how standard-of-care decisions are much less complicated for inoperable stage II-III NSCLC.”

Read further
Source: Drew Moghanaki/X

Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.

He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).